Project Materials

THE DEVELOPMENT AND MASS PRODUCTION OF CHEMICAL SYNTHESIZED DRUGS HAVE REVOLUTIONIZED HEALTHCARE IN MOST PART OF THE WORLD

Chapter one

INTRODUCTION

Background of the Study

The use of pharmaceuticals in healthcare has helped to manage and treat a wide range of diseases and ailments. However, the development and widespread use of chemically synthesised medications has transformed healthcare in most regions of the world.

Chemical synthesis is the process of creating medications through chemical processes rather than extracting active components from natural sources.

This approach has enabled the development of focused and effective treatments that can be generated at a big scale. The availability of these pharmaceuticals has greatly improved public health and quality of life for millions of people around the world.

Chemical manufacture of pharmaceuticals began in the early twentieth century, when scientists began to investigate drug composition and effects on the human body (Krebs, 2001).

The first successful chemical synthesis of a drug occurred in 1907, when German chemist Paul Ehrlich created Salvarsan, a medication used to cure syphilis. This achievement paved the path for the large-scale manufacture of chemically synthesised pharmaceuticals.

Since then, the discovery and mass manufacture of chemically synthesised medications has advanced significantly, and they are now a vital component of modern healthcare.

The availability of these medications has resulted in substantial gains in public health by allowing treatments for previously incurable diseases and ailments. Chemically synthesised medications enable healthcare providers to successfully manage and treat a wide range of diseases and ailments.

One of the primary advantages of chemically synthesised medications is their capacity to target specific diseases or conditions. The chemical structure of the medicine can be tailored to interact with certain molecules or enzymes in the body, resulting in a more targeted therapy strategy. This enables a more effective treatment strategy, lowering the likelihood of unwanted effects while increasing patient outcomes.

Chemically synthesised medications are also less expensive than drugs produced from natural sources. Natural sources of pharmaceuticals necessitate substantial research and development to separate and extract the active chemicals, making them a more expensive treatment choice.

Chemical synthesis, on the other hand, is a cost-effective approach of drug production that allows for the mass production of pharmaceuticals at a cheap cost (Zhang et al., 2018).

Furthermore, chemical synthesis of pharmaceuticals has allowed for the discovery of new drugs that would not have been possible to produce naturally. Researchers can alter the chemical structure of existing medications or produce whole new molecules, resulting in more effective therapies for a variety of diseases and disorders.

The effects of chemically synthesised medications on public health have been considerable. These medications have given successful therapies for a wide range of diseases and ailments, leading to better patient outcomes and a higher quality of life.
Chemically synthesised medications, such as antibiotics, have revolutionised the treatment of infectious diseases, drastically lowering bacterial infection death rates.

Chemically synthesised medications have also played an important part in the treatment of chronic disorders like cancer, diabetes, and heart failure.

chronic medications have given successful treatments for managing and controlling chronic illnesses, allowing patients to enjoy longer, healthier lives.

Chemically synthesised medications, such as insulin, have revolutionised diabetes treatment, allowing patients to manage their condition while avoiding disease consequences (Levy et al., 2018).

Furthermore, the availability of synthetic medications has had a substantial impact on global health. These medications have been crucial in the elimination of smallpox as well as the control of polio and malaria (Hotez et al., 2020).

The availability of effective medicines has also resulted in better public health outcomes in underdeveloped countries, where infectious and chronic diseases are prevalent.

Statement of the Problem

Despite the tremendous advantages of chemically synthesised medications in revolutionising healthcare, there are serious questions regarding their safety and efficacy. One of the primary concerns with chemically synthesised medications is the possibility of unwanted consequences.

Because of their targeted nature, many medications can have unanticipated side effects on other sections of the body. Another problem is the development of antibiotic resistance as a result of excessive usage of chemically synthesised antibiotics.

This has become a major public health concern as antibiotic-resistant bacteria spread, making it more difficult to treat infectious infections.

Furthermore, the cost of chemically synthesised medications can be prohibitive for some people. Although chemically synthesised pharmaceuticals are often less expensive than natural sources of drugs, they can still be costly, particularly for people without access to healthcare insurance.

Another issue is the possibility of using chemical synthesis to produce illicit drugs. The chemical synthesis of drugs has made it easier for illegal drug makers to produce and transport narcotics, resulting in increased drug abuse and addiction. Finally, there is worry about the environmental impact of mass producing chemically synthesised medications.

The manufacture of these pharmaceuticals may result in the emission of harmful chemicals and trash, causing environmental deterioration and potential health hazards for those in the surrounding areas.

In conclusion, while the creation and large manufacture of chemically synthesised medications